MedPlus Health Services Limited (BOM:543427)
India · Delayed Price · Currency is INR 900.55
+24.55 (2.80%)
At close: Jun 2, 2026
MedPlus Health Services Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, MedPlus Health Services stock has a consensus rating of "Strong Buy" and an average price target of ₹1,163. The average 1-year stock price forecast is 29.14% higher than the current stock price, while the lowest is ₹1,060 (+17.71%) and the highest is ₹1,271 (+41.14%).
Price Target: ₹1,163 (+29.14%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MedPlus Health Services stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Financial Forecast
Revenue This Year
78.27B
from 68.92B
Increased by 13.55%
Revenue Next Year
90.56B
from 78.27B
Increased by 15.71%
EPS This Year
21.60
from 18.29
Increased by 18.12%
EPS Next Year
27.32
from 21.60
Increased by 26.47%
Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 80.6B | ||
| Avg | 78.3B | ||
| Low | 75.6B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 16.9% | ||
| Avg | 13.6% | ||
| Low | 9.7% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 23.50 | ||
| Avg | 21.60 | ||
| Low | 20.00 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 28.5% | ||
| Avg | 18.1% | ||
| Low | 9.3% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.